201 related articles for article (PubMed ID: 9797701)
1. Screening women aged less than 50 years with a family history of breast cancer.
Kollias J; Sibbering DM; Blamey RW; Holland PA; Obuszko Z; Wilson AR; Evans AJ; Ellis IO; Elston CW
Eur J Cancer; 1998 May; 34(6):878-83. PubMed ID: 9797701
[TBL] [Abstract][Full Text] [Related]
2. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
[TBL] [Abstract][Full Text] [Related]
3. Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.
Walker MJ; Mirea L; Cooper K; Nabavi M; Glendon G; Andrulis IL; Knight JA; O'Malley FP; Chiarelli AM
Fam Cancer; 2014 Jun; 13(2):163-72. PubMed ID: 24097051
[TBL] [Abstract][Full Text] [Related]
4. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
[TBL] [Abstract][Full Text] [Related]
5. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
6. Earlier detection of breast cancer by surveillance of women at familial risk.
Tilanus-Linthorst MM; Bartels CC; Obdeijn AI; Oudkerk M
Eur J Cancer; 2000 Mar; 36(4):514-9. PubMed ID: 10717529
[TBL] [Abstract][Full Text] [Related]
7. Screening by mammography, women with a family history of breast cancer.
Lalloo F; Boggis CR; Evans DG; Shenton A; Threlfall AG; Howell A
Eur J Cancer; 1998 May; 34(6):937-40. PubMed ID: 9797712
[TBL] [Abstract][Full Text] [Related]
8. Interval cancers in the Dutch breast cancer screening programme.
Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
[TBL] [Abstract][Full Text] [Related]
9. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
10. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening and management.
Forrest AP; Anderson ED
Med J Aust; 1999 Nov; 171(9):479-84. PubMed ID: 10615342
[No Abstract] [Full Text] [Related]
12. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
13. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?
Hoff SR; Klepp O; Hofvind S
J Med Screen; 2012 Dec; 19(4):177-83. PubMed ID: 23486698
[TBL] [Abstract][Full Text] [Related]
15. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
16. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.
Kerlikowske K; Barclay J; Grady D; Sickles EA; Ernster V
J Natl Cancer Inst; 1997 Jan; 89(1):76-82. PubMed ID: 8978410
[TBL] [Abstract][Full Text] [Related]
17. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
[TBL] [Abstract][Full Text] [Related]
18. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.
Randall D; Morrell S; Taylor R; Hung WT
Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941
[TBL] [Abstract][Full Text] [Related]
19. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
[TBL] [Abstract][Full Text] [Related]
20. Should breast screening programmes limit their detection of ductal carcinoma in situ?
Evans AJ; Blanks RG
Clin Radiol; 2002 Dec; 57(12):1086-9. PubMed ID: 12475533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]